Alectinib Plus Atezolizumab Is Safe in Patients With ALK+ Lung Cancer

Bryant FurlowJun 2, 2018Combining the ALK inhibitor with this immunotherapeutic agent had an acceptable safety profile, according to a team of South Korean investigators.

Source: CancerNetwork - June 2, 2018 Category: Cancer & Oncology Authors: A Source Type: news